Back to CYTR Stock Lookup

CYTR Related Corporate News

May 6, 2013 08:36 AM CytRx Corp (CYTR) Recommended to Continue Aldoxorubicin Phase 2b to Completion

Nov 15, 2012 09:01 AM CytRx Corp (CYTR) Reports Encouraging Data from Aldoxorubicin Phase 1b/2

Oct 19, 2012 12:18 PM CytRx (CYTR) Underwriters Exercise Full 1.2M Common Overallotment

Oct 18, 2012 06:39 AM CytRx (CYTR) Prices 8M Offering; Sees Gross Proceeds of $20M

Oct 15, 2012 08:38 AM CytRx (CYTR) Initiates Aldoxorubicin Phase 1b

Oct 1, 2012 08:32 AM CytRx Corp (CYTR) Updates on Encouraging Data from Aldoxorubicin Phase 1b/2

Jul 25, 2012 08:34 AM CytRx Corp (CYTR) Commences Adoxorubicin Phase 1b in Advanced Solid Tumors

Jul 2, 2012 08:37 AM CytRx (CYTR) Receives EPO Patent for Linker Platform; Giver 'Aldoxorubucin' Name to INNO-206

Jun 4, 2012 07:49 AM CytRx Corp. (CYTR) to Present Encouraging Data from INNO-206 Phase 1b/2 at ASCO

Jun 1, 2012 08:31 AM CytRx (CYTR) Back in Compliance for Continued Nasdaq Listing

May 29, 2012 08:35 AM CytRx (CYTR) Reports Publication of INNO-206 Findings in Multiple Myeloma

Apr 26, 2012 08:31 AM CytRx (CYTR) Commences INNO-206 Phase 2

Apr 23, 2012 08:34 AM CytRx (CYTR) Announces Favorable Ruling from NASDAQ Panel, Announces Extension

Feb 17, 2012 08:32 AM CytRx (CYTR) Receives Nasdaq Listing Requirements Notice

Dec 22, 2011 08:39 AM CytRx (CYTR) Initiates Dxorubicin Conjugate INNO-206 Phase 2b

Dec 12, 2011 08:31 AM CytRx (CYTR) Reports Favorable Phase 2 ENABLE in Certain B-CLL Patients

Oct 31, 2011 08:32 AM CytRx (CYTR) Reports Favorable INNO-206 Results from Ongoing Phase 1b/2

Aug 1, 2011 08:50 AM CytRx Corp (CYTR) Announces INNO-206 Combination Therapy Could Reduce Toxicity and Improve Tumor Response

Jul 6, 2011 08:47 AM CytRx's (CYTR) Tumor-Targeted Doxorubicin Conjugate Delivers Doxorubcin Safely at Higher Doese

Apr 28, 2011 09:00 AM CytRx's (CYTR) INNO-206 Receives Orphan Drug Designation from U.S. FDA

Apr 20, 2011 08:35 AM CytRx (CYTR) Aims to Accelerate Enrollment in Tamibarotene Phase 2b with Site Expansion

Apr 11, 2011 09:26 AM CytRx (CYTR) Gets Stake in ADVENTRX Pharma (ANX) Following SynthRx Acquisition

Mar 17, 2011 08:36 AM CytRx (CYTR) Initiates INNO-206 Phase Ib

Feb 14, 2011 09:11 AM CytRx (CYTR) to Receive Stake in ADVENTRX (ANX) Under SynthRx Acquisition Agreement

Feb 8, 2011 08:33 AM CytRx (CYTR) Announces Positive Data for Bafetnib in Preventing Bone Loss

Jan 12, 2011 08:43 AM CytRx (CYTR) Receives $7M from RXi (RXII) Sale

Nov 10, 2010 08:55 AM CytRx (CYTR) Initiates Bafetinib Pharmacokinetic in Patients with Recurring Brain Tumors

Nov 2, 2010 08:46 AM CytRx Corp. (CYTR) Receives $735K Grant for INNO-206 Programs

Jun 7, 2010 09:33 AM CytRx Corp. (CYTR) Gets U.S. Patent for Leukemia Treatment Bafetinib

May 28, 2010 01:02 PM CytRx (CYTR) Initiates Phase 2 Trial with Bafetinib in B-cell Chronic Lymphocytic Leukemia

May 27, 2010 08:35 AM CytRx Corp. (CYTR) Announces Positive Data for Drug Candidate Bafetinib

Apr 20, 2010 08:46 AM CytRx Corp's (CYTR) Bafetinib Receives Positive Opinion from COMP of the EMEA

Apr 7, 2010 08:44 AM CytRx Corp (CYTR) Announces Bafetinib Phase 2

Mar 23, 2010 01:19 PM CytRx Corp. (CYTR) To Sell 675K Common Back to RXi Pharma (RXII); CYTR to Receive $3.8M in Deal

Jan 13, 2010 08:42 AM CytRx (CYTR) to Initiate Phase 2 Proof-of-Concept Trial to Evaluate Efficacy/Safety of Bafetinib

Dec 7, 2009 09:23 AM CytRx (CYTR) Announces Presentation of Phase 2 Results for Tamibartoene at ASH Meeting

Dec 2, 2009 08:42 AM CytRx (CYTR) Receives Revised Clinical Protocal from U.S. FDA for ALS Therapeutic Drug Arimoclomol

Sep 14, 2009 09:11 AM CytRx (CYTR) and Cephalon (CEPH) Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia

Sep 10, 2009 08:47 AM CytRx (CYTR) Secures Key European Patent for Arimoclomol

Aug 24, 2009 09:22 AM CytRx (CYTR) Announces Positive Results in Arimoclomol Animal Stroke Study

Aug 12, 2009 08:57 AM CytRx's (CYTR) Drug Candidate INNO-206 Dramatically Inhibited Tumor Growth in Animal Model of Small Cell Lung Cancer

Jul 28, 2009 09:04 AM CytRx (CYTR) Jumping On Drug Candidate INNO-206 Results in Ovarian Tumor Shrinkage in Animal Trials

Jul 27, 2009 09:13 AM CytRx (CYTR) Announces Compliance with All NASDAQ Listing Requirements

Jul 24, 2009 08:58 AM CytRx's (CYTR) Tamibarotene Receives Positive Opinion from the Committee for Orphan Medicinal Products in the EU for Treatment of APL

Jul 20, 2009 08:38 AM CytRx's (CYTR) INNO-206 Significantly Inhibits Pancreatic Cancer Growth in Animal Trials

Jun 29, 2009 08:47 AM CytRx (CYTR) Reports Favorable Progress Update for Ongoing Phase 2 STAR-1 Trial of Tamibarotene

Jun 25, 2009 08:44 AM CytRx (CYTR) to Present Statistically Significant Evidence of Arimoclomol's Ability to Protect Experimental Animals from Effects of Hypoxia

Dec 3, 2008 08:34 AM CytRx (CYTR) Unveils New Corporate Strategy

Jun 2, 2008 08:39 AM CytRx Corp. (CYTR) to Present Positive Data on Iroxanadine at the Third Congress of World Union of Wound Healing Socieities

Apr 23, 2008 08:33 AM CytRx (CYTR) Announces Discovery of Novel Compounds that Amplify Chaperone Response to Cell Stress

Back to CYTR Stock Lookup